Sinulariolide Suppresses Inflammation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis and Mitigates Collagen-Induced Arthritis Symptoms in Mice

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Nov 11

PMID 39525321

Authors

Sen-Wei Tsai

Yu-Chieh Cheng

Ya-Hsuan Chao

Deng-Ho Yang

Affiliations

Soon will be listed here.

Abstract

Background: Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by active polyarthritis, which leads to functional loss and joint deformities. Natural compounds derived from marine organisms are considered valuable immune-modulating agents. This study aimed to assess the anti-inflammatory effect of sinulariolide, a soft coral-derived compound, on RA fibroblast-like synoviocytes and its therapeutic efficacy against collagen-induced arthritis (CIA).

Methods: To determine the effects of sinulariolide on tumor necrosis factor-alpha (TNF-α)-induced inflammation, MH7A cells pre-treated with 10 ng/mL TNF-α for 24 h were treated with sinulariolide. The effect of sinulariolide on proinflammatory cytokine expressions at both the mRNA and protein levels in the MH7A cells was assessed using real-time-polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA). Further, we analyzed the effect of sinulariolide on the activation of mitogen-activated protein kinase (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathways using Western blotting and the TransAM NF-κB p65 kit. To comprehensively evaluate the potential application of sinulariolide in the treatment of inflammatory diseases, we used a well-established collagen-induced arthritis (CIA) mouse model. We examined the tissue sections of the ankle joints of the mice, assessed synovial hyperplasia, inflammatory cell infiltration, and cartilage damage, and used ELISA to analyze changes in cytokine expression in the hind paw tissues.

Results: MH7A cells treated with sinulariolide showed a notable reduction in the expression of proinflammatory cytokines, which could be due to decreased activation of the MAPK and NF-kB pathways. Additionally, sinulariolide-treated mice showed significantly reduced joint swelling and lower clinical arthritis scores than those in the normal and control groups. Significant reductions in synovial hyperplasia, inflammatory cell infiltration, and cartilage damage were observed in the tissue sections of the ankle joints of the mice treated with sinulariolide. Furthermore, the expression of inflammatory cytokines in the hind paw tissue of the mice treated with sinulariolide was significantly decreased.

Conclusion: Sinulariolide inhibited the progression of inflammation in MH7A cells. Sinulariolide treatment significantly reduced clinical arthritis symptoms and histological inflammatory responses in mice with CIA. Sinulariolide may serve as a potential therapeutic agent for RA.

References

Cheng T, Din Z, Su J, Wu Y, Liu C . Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells. Mar Drugs. 2017; 15(8). PMC: 5577593. DOI: 10.3390/md15080238. View

Schett G, Zwerina J, Firestein G . The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis. 2007; 67(7):909-16. PMC: 2754165. DOI: 10.1136/ard.2007.074278. View

Bottini N, Firestein G . Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2012; 9(1):24-33. PMC: 3970924. DOI: 10.1038/nrrheum.2012.190. View

Hsiao K, Wu Y, Liu Z, Chuang C, Huang H, Kuo S . Anticancer Effects of Sinulariolide-Conjugated Hyaluronan Nanoparticles on Lung Adenocarcinoma Cells. Molecules. 2016; 21(3):297. PMC: 6274027. DOI: 10.3390/molecules21030297. View

Sharma R, Sharma C, Mahajan A . Biological agents targeting beyond TNF-alpha. Indian J Crit Care Med. 2009; 12(4):181-9. PMC: 2738326. DOI: 10.4103/0972-5229.45079. View

Tong Y, Li X, Deng Q, Shi J, Feng Y, Bai L . Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis. Front Pharmacol. 2023; 14:1230293. PMC: 10400780. DOI: 10.3389/fphar.2023.1230293. View

Tsuchiya H, Ota M, Fujio K . Multiomics landscape of synovial fibroblasts in rheumatoid arthritis. Inflamm Regen. 2021; 41(1):7. PMC: 7919303. DOI: 10.1186/s41232-021-00157-8. View

Zhang Q, Liu J, Zhang M, Wei S, Li R, Gao Y . Apoptosis Induction of Fibroblast-Like Synoviocytes Is an Important Molecular-Mechanism for Herbal Medicine along with its Active Components in Treating Rheumatoid Arthritis. Biomolecules. 2019; 9(12). PMC: 6995542. DOI: 10.3390/biom9120795. View

Murayama M, Shimizu J, Miyabe C, Yudo K, Miyabe Y . Chemokines and chemokine receptors as promising targets in rheumatoid arthritis. Front Immunol. 2023; 14:1100869. PMC: 9968812. DOI: 10.3389/fimmu.2023.1100869. View

10.

Mousavi M, Karami J, Aslani S, Tahmasebi M, Vaziri A, Jamshidi A . Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe. Auto Immun Highlights. 2021; 12(1):3. PMC: 7863458. DOI: 10.1186/s13317-020-00145-x. View

11.

Liu F, Feng X, Zhu S, Huang H, Chen Y, Pan Y . Sonic Hedgehog Signaling Pathway Mediates Proliferation and Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis MAPK/ERK Signaling Pathway. Front Immunol. 2018; 9:2847. PMC: 6290332. DOI: 10.3389/fimmu.2018.02847. View

12.

Neoh C, Wang R, Din Z, Su J, Chen Y, Tsai F . Induction of apoptosis by sinulariolide from soft coral through mitochondrial-related and p38MAPK pathways on human bladder carcinoma cells. Mar Drugs. 2012; 10(12):2893-911. PMC: 3528132. DOI: 10.3390/md10122893. View

13.

Skartsis N, Peng Y, Ferreira L, Nguyen V, Ronin E, Muller Y . IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function. Front Immunol. 2022; 12:783282. PMC: 8732758. DOI: 10.3389/fimmu.2021.783282. View

14.

Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

15.

Lin Y, Jean Y, Lee H, Chen W, Sun Y, Su J . A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis. PLoS One. 2013; 8(5):e62926. PMC: 3652811. DOI: 10.1371/journal.pone.0062926. View

16.

Chen Y, Su J, Tsao C, Hung C, Chao H, Lin J . Sinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2α/ATF4/CHOP pathway. Molecules. 2013; 18(9):10146-61. PMC: 6270604. DOI: 10.3390/molecules180910146. View

17.

Perricone C, Shoenfeld Y . [Mosaic of Autoimmunity- the Novel Factors of Autoimmune Diseases Revisited]. Harefuah. 2020; 159(1):57-60. View

18.

Kang H, Lee H, Seo C, Park Y . Antimicrobial and Immunomodulatory Properties and Applications of Marine-Derived Proteins and Peptides. Mar Drugs. 2019; 17(6). PMC: 6628016. DOI: 10.3390/md17060350. View

19.

Jang S, Kwon E, Lee J . Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. Int J Mol Sci. 2022; 23(2). PMC: 8780115. DOI: 10.3390/ijms23020905. View

20.

McInnes I, Schett G . Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007; 7(6):429-42. DOI: 10.1038/nri2094. View